About
Napoleone Ferrara (born 26 July 1956, Catania), is an Italian-American molecular biologist who joined University of California, San Diego Moores Cancer Center in 2013 after a career in Northern California at the biotechnology giant Genentech, where he pioneered the development of new treatments for angiogenic diseases such as cancer, age-related macular degeneration (AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These findings helped lead to development of the first clinically available angiogenesis inhibitor, bevacizumab (Avastin), which prevents the growth of new blood vessels into a solid tumor and which has become part of standard treatment for a variety of cancers. Ferrara's work led also to the development of ranibizumab (Lucentis), a drug that is highly effective at preventing vision loss in intraocular neovascular disorders.
Key details
| Born |
26 July 1956 (age 68)
|
| Zodiac | Leo |
| Tags | Add tag |
Partner
Family members
Parents
Siblings
Other family members
Connections
Friends & associates
Napoleone Ferrara dating history
0Children
0Scholars
Family
Parents
Siblings
Children
Other family members
Friends & associates
Missing information for Napoleone Ferrara
- missing gender
- missing height
- missing hair color
- missing eye color
- missing ethnicity
- add banner photo
- add photos to gallery
- missing current partner
Lists
Facts and figures
Similar profiles
Activity
Top contributors today
Tags
Featured contributors
Couples by country
USA · UK · Canada · Australia · France · Germany · India · China · South Korea · Japan · Spain · MexicoCouples by decade
1900s · 1910s · 1920s · 1930s · 1940s · 1950s · 1960s · 1970s · 1980s · 1990s · 2000s · 2010s · 2020s
